218 related articles for article (PubMed ID: 3117884)
1. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
Brown TJ; Lioubin MN; Marquardt H
J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
[TBL] [Abstract][Full Text] [Related]
2. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
3. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
5. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
6. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
Defrance T; Aubry JP; Vanbervliet B; Banchereau J
J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibitory activities secreted by THP-1 leukemia cells and regulation by interferon-gamma.
Gaffney EV
Growth Regul; 1991 Sep; 1(3):85-94. PubMed ID: 1842567
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
Dumont FJ; Kastner CA
J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
[TBL] [Abstract][Full Text] [Related]
11. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma.
Boutten A; Venembre P; Seta N; Hamelin J; Aubier M; Durand G; Dehoux MS
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):511-20. PubMed ID: 9533938
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes.
Fargeas C; Wu CY; Nakajima T; Cox D; Nutman T; Delespesse G
Eur J Immunol; 1992 Aug; 22(8):2173-6. PubMed ID: 1386318
[TBL] [Abstract][Full Text] [Related]
14. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
15. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
16. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
[TBL] [Abstract][Full Text] [Related]
20. The differential inhibitory effect of lymphotoxin and immune interferon on normal and malignant lymphoid cells.
Powell MB; Conta BS; Horowitz M; Ruddle NH
Lymphokine Res; 1985; 4(1):13-26. PubMed ID: 2984482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
